Web• Chairman, CEO Ruthigen, Inc. • IPO experience, including raising $170M in capital • FDA and CE approvals of multiple drugs and devices FOUNDER, CHAIRMAN AND CEO Bill Watson • Over 10 years experience in healthcare startups • Investment Banker completed over $400M in transactions • Director of National Investment Bankers Association WebJun 15, 2015 · Pulmatrix, Inc. entered into an agreement and plan of merger to acquire Ruthigen, Inc. (NasdaqCM:RTGN) in a reverse merger transaction on March 13, 2015. As …
Did you know?
WebMore than 20 years of experience in the global healthcare industry. Founder, Chairman, CEO Micromed Labs, Oculus Innovative, Ruthigen, Inc. IPO experience, including raising $170M in capital. Multiple FDA and CE approvals of drugs and devices, and regulatory readiness. 36 patents in areas of anti-infective and medical devices. WebRuthigen is a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics designed to prevent and treat infection in …
WebEX-1.1 2 v355829_ex1-1.htm EXHIBIT 1.1 . Exhibit 1.1 . UNDERWRITING AGREEMENT . between . RUTHIGEN, INC. and . AEGIS CAPITAL CORP., as Representative of the Several … WebJul 17, 2014 · About Ruthigen, Inc. Ruthigen is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics designed to prevent and treat infection in invasive applications. The Company's lead drug candidate, RUT58-60, is a broad-spectrum anti-infective that Ruthigen is developing for the …
Web(1) The number of shares of common stock, par value $0.0001 per share (“Common Stock”), of Ruthigen, Inc. (the “Registrant”), stated above consists of the aggregate number of shares which may be sold upon the exercise of options or issuance of stock-based awards which may hereafter be granted under the Ruthigen, Inc. 2013 Employee, Director and … WebFeb 1, 2024 · Former name: Ruthigen, Inc., date of change: 2013-04-11. Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the development and discovery of novel inhaled therapeutics products. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov, and Robert S. Langer, Jr. on June 15, 2015 and …
WebFOUNDER, CHAIRMAN AND CEO More than 20 years of experience in the global healthcare industry Founder, Chairman, CEO Micromed Labs, Oculus Innovative, Ruthigen, Inc. IPO experience, including raising $170M in capital Multiple FDA and CE approvals of drugs and devices, and regulatory readiness.
WebJan 10, 2013 · Ruthigen intends to identify a partner for its European drug indication as well as file an S-1 registration statement to fund its pivotal drug program in the United States. Upon completion of a public offering, the entities will operate as independent entities. men\u0027s rugby league world cup fixturesWebPhone Number 707-525-9900 They are a biopharmaceutical company focused on the discovery, development, and commercialization of pharmaceutical-grade hypochlorous … how much vitamin c when fighting a coldWebHuggins Insurance is a client-focused, independent agency specializing in business, nonprofit, and personal insurance. men\u0027s rugby league world cup resultsWebExecution Version . SEPARATION AGREEMENT . This Separation Agreement (this “Agreement”), by and between Ruthigen, Inc., a Nevada corporation (“Ruthigen”), and … men\u0027s rugby league world cup 2022 resultsWebExecution Version . SEPARATION AGREEMENT . This Separation Agreement (this “Agreement”), by and between Ruthigen, Inc., a Nevada corporation (“Ruthigen”), and Oculus Innovative Sciences, Inc., a Delaware corporation (“Oculus” and, together with Ruthigen, the “Parties” and each, a “Party”), is made and entered into as of August 2, 2013, and shall be … men\u0027s ruby cufflinksWebwww.ruthigen.com men\u0027s royal blue shirtsWebRUTHIGEN, INC. is a Delaware Corporation filed on September 25, 2013. The company's File Number is listed as 5404994. The Registered Agent on file for this company is … men\u0027s rubber mocs rain shoes